Trial intelligence / Profile preview

Early eplerenone in acute myocardial infarction

2010-019844-38Phase 4Completed

Sponsor
Pfizer
Start
Jun 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Eplerenone with Placebo (2 arms). Primary endpoints: Composite primary endpoint and Cardiovascular morbidity and mortality. Started Jun 2010; status: completed.

02

Drugs

eplerenone
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2010-019844-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019844-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call